Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

7 treatments under study, led by Actazin Chewable Tablet

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 2/3 (1)

Trial Status

Completed2
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT06836024Phase 2/3Not Yet Recruiting

A Trial of Actazin Versus PEG 3350 for Maintenance Therapy in Children With Constipation

NCT05040139CompletedPrimary

A Comparison of Quality of Life Between MAlone Procedure and Percutaneaous Endoscopic Caecostomy in Patients With Antegrade Colonic Enema

NCT02419924Not ApplicableCompletedPrimary

Proof of Concept: "Bottom's Up" Seat to Treat Constipation

Showing all 3 trials

Research Network

Common Treatments

  • Actazin Chewable Tablet1
  • Malone Procedure1
  • Peg 33501
  • Chewable Tablet1
  • Maltodextrin Placebo1

Active Sponsors

  • Mayo Clinic1
  • Hamilton Health Sciences Corporation1
  • Nantes University Hospital1

Top Investigators

Related Conditions

  • Constipation Functional1
  • Fecal Incontinence With Fecal Urgency1
  • Pelvic Floor Incompetency1
  • Constipation1

Activity Timeline